| scholarly article | Q13442814 |
| P2093 | author name string | Brown JE | |
| Karlsson KA | |||
| Lindberg AA | |||
| Schultz JE | |||
| Strömberg N | |||
| Westling-Ryd M | |||
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Shigella dysenteriae | Q265094 |
| P304 | page(s) | 1779-1785 | |
| P577 | publication date | 1987-02-01 | |
| P1433 | published in | Journal of Biological Chemistry | Q867727 |
| P1476 | title | Identification of the carbohydrate receptor for Shiga toxin produced by Shigella dysenteriae type 1. | |
| P478 | volume | 262 |
| Q36913900 | "Alternative" endocytic mechanisms exploited by pathogens: new avenues for therapeutic delivery? |
| Q89581354 | A genome-wide CRISPR/Cas9 screen reveals that the aryl hydrocarbon receptor stimulates sphingolipid levels |
| Q35125841 | A novel mechanism of bacterial toxin transfer within host blood cell-derived microvesicles |
| Q35104239 | A system for production and rapid purification of large amounts of the Shiga toxin/Shiga-like toxin I B subunit |
| Q35487599 | Activation of Shiga-like toxins by mouse and human intestinal mucus correlates with virulence of enterohemorrhagic Escherichia coli O91:H21 isolates in orally infected, streptomycin-treated mice |
| Q35109009 | Acute renal tubular necrosis and death of mice orally infected with Escherichia coli strains that produce Shiga-like toxin type II |
| Q56344646 | After the fact(or): post-transcriptional gene regulation in enterohemorrhagic O157:H7 |
| Q38354498 | Aglycone modulation of glycolipid receptor function |
| Q41285938 | Alpha 1,4galactosyltransferase activity and Gb3Cer expression in human leukaemia/lymphoma cell lines |
| Q35586936 | Analysis of Shiga toxin subunit association by using hybrid A polypeptides and site-specific mutagenesis |
| Q35169600 | Bacterial Adhesion of Streptococcus suis to Host Cells and Its Inhibition by Carbohydrate Ligands. |
| Q34001958 | Binding of Actinobacillus pleuropneumoniae lipopolysaccharides to glycosphingolipids evaluated by thin-layer chromatography. |
| Q38306821 | Binding profiles and cytokine-inducing effects of fish rhamnose-binding lectins on Burkitt's lymphoma Raji cells. |
| Q40705289 | Bovine ileal intraepithelial lymphocytes represent target cells for Shiga toxin 1 from Escherichia coli |
| Q39824731 | Burkholderia (basonym Pseudomonas) cepacia binding to lipid receptors. |
| Q36363421 | CD19 has a potential CD77 (globotriaosyl ceramide)-binding site with sequence similarity to verotoxin B-subunits: implications of molecular mimicry for B cell adhesion and enterohemorrhagic Escherichia coli pathogenesis |
| Q35578982 | Carbohydrate-dependent binding of the cell-free hemagglutinin of Vibrio cholerae to glycoprotein and glycolipid |
| Q39114334 | Cell density-induced changes in lipid composition and intracellular trafficking |
| Q42859529 | Characterization of Shiga-like toxin I B subunit purified from overproducing clones of the SLT-I B cistron |
| Q39946072 | Characterization of repetitive sequences controlling phase variation of Haemophilus influenzae lipopolysaccharide |
| Q34596075 | Characterization of urinary tract infection-associated Shiga toxin-producing Escherichia coli. |
| Q34166278 | Charged and hydrophobic surfaces on the a chain of shiga-like toxin 1 recognize the C-terminal domain of ribosomal stalk proteins |
| Q39654288 | Cloned Shiga toxin 2 B subunit induces apoptosis in Ramos Burkitt's lymphoma B cells |
| Q36215407 | Cloning and sequencing of a Shiga-like toxin type II variant from Escherichia coli strain responsible for edema disease of swine |
| Q33801217 | Comparison of binding platforms yields insights into receptor binding differences between shiga toxins 1 and 2 |
| Q36977977 | Comparison of the glycolipid receptor specificities of Shiga-like toxin type II and Shiga-like toxin type II variants |
| Q33498518 | Comparison of the western blot assay with the neutralizing-antibody and enzyme-linked immunosorbent assays for measuring antibody to verocytotoxin 1. |
| Q36949679 | Construction of stable LamB-Shiga toxin B subunit hybrids: analysis of expression in Salmonella typhimurium aroA strains and stimulation of B subunit-specific mucosal and serum antibody responses |
| Q33852500 | Consumption of human milk glycoconjugates by infant-associated bifidobacteria: mechanisms and implications. |
| Q39859453 | Cytotoxicity of a shiga toxin A subunit-CD4 fusion protein to human immunodeficiency virus-infected cells |
| Q72996597 | Development of recombinant B subunit of Shiga-like toxin 1 as a probe to detect carbohydrate ligands in immunochemical and flowcytometric application |
| Q36999010 | Direct cytotoxic action of Shiga toxin on human vascular endothelial cells |
| Q41685673 | Endocytosis and intracellular transport of the glycolipid-binding ligand Shiga toxin in polarized MDCK cells |
| Q41575546 | Endocytosis from coated pits of Shiga toxin: a glycolipid-binding protein from Shigella dysenteriae 1. |
| Q37337686 | Enterohemorrhagic Escherichia coli suppresses inflammatory response to cytokines and its own toxin |
| Q37433674 | Epigallocatechin-3-gallate suppresses galactose-alpha1,4-galactose-1beta,4-glucose ceramide expression in TNF-alpha stimulated human intestinal epithelial cells through inhibition of MAPKs and NF-kappaB. |
| Q39195548 | Escherichia coli, cattle and the propagation of disease |
| Q41118137 | Establishment of a monoclonal antibody directed against Gb3Cer/CD77: a useful immunochemical reagent for a differentiation marker in Burkitt's lymphoma and germinal centre B cells |
| Q35779632 | Evidence that the A2 fragment of Shiga-like toxin type I is required for holotoxin integrity |
| Q24633154 | Evidence that verotoxins (Shiga-like toxins) from Escherichia coli bind to P blood group antigens of human erythrocytes in vitro |
| Q34372184 | Functional analysis of the Shiga toxin and Shiga-like toxin type II variant binding subunits by using site-directed mutagenesis. |
| Q37295263 | Genetic basis of virulence in Shigella species |
| Q33428897 | Genomic Comparison of Two O111:H- Enterohemorrhagic Escherichia coli Isolates from a Historic Hemolytic-Uremic Syndrome Outbreak in Australia |
| Q40835280 | Globotriaosyl ceramide modulates interferon-alpha-induced growth inhibition and CD19 expression in Burkitt's lymphoma cells |
| Q28072827 | Glycosphingolipid-Protein Interaction in Signal Transduction |
| Q24669689 | Hemolytic uremic syndrome-associated Shiga toxins promote endothelial-cell secretion and impair ADAMTS13 cleavage of unusually large von Willebrand factor multimers |
| Q41215219 | Host-specificity of uropathogenic Escherichia coli depends on differences in binding specificity to Gal alpha 1-4Gal-containing isoreceptors |
| Q34290908 | Human intestinal tissue and cultured colonic cells contain globotriaosylceramide synthase mRNA and the alternate Shiga toxin receptor globotetraosylceramide. |
| Q35869062 | Identification of PblB mediating galactose-specific adhesion in a successful Streptococcus pneumoniae clone |
| Q38331987 | Identification of a novel streptococcal adhesin P (SadP) protein recognizing galactosyl-α1-4-galactose-containing glycoconjugates: convergent evolution of bacterial pathogens to binding of the same host receptor |
| Q36129775 | Identification of three amino acid residues in the B subunit of Shiga toxin and Shiga-like toxin type II that are essential for holotoxin activity |
| Q40242899 | Importance of glycolipid synthesis for butyric acid-induced sensitization to shiga toxin and intracellular sorting of toxin in A431 cells. |
| Q37006892 | In vivo formation of hybrid toxins comprising Shiga toxin and the Shiga-like toxins and role of the B subunit in localization and cytotoxic activity |
| Q33837961 | Induction of verotoxin sensitivity in receptor-deficient cell lines using the receptor glycolipid globotriosylceramide |
| Q36634680 | Infection by verocytotoxin-producing Escherichia coli |
| Q38359579 | Influence of phospholipid chain length on verotoxin/globotriaosyl ceramide binding in model membranes: comparison of a supported bilayer film and liposomes |
| Q37222599 | Instability of toxin A subunit of AB(5) toxins in the bacterial periplasm caused by deficiency of their cognate B subunits |
| Q35490172 | Interaction of verotoxin 2e with pig intestine. |
| Q40518466 | Intracellular d-Serine Accumulation Promotes Genetic Diversity via Modulated Induction of RecA in Enterohemorrhagic Escherichia coli. |
| Q40158837 | Isolation of Shiga toxin-resistant Vero cells and their use for easy identification of the toxin |
| Q78032181 | Lack of Shiga-like toxin binding sites in germinal centres of mouse lymphoid tissues |
| Q35119236 | Lipid-mediated endocytosis. |
| Q28253198 | Lipids in host-pathogen interactions: pathogens exploit the complexity of the host cell lipidome |
| Q34276994 | Lysogeny with Shiga toxin 2-encoding bacteriophages represses type III secretion in enterohemorrhagic Escherichia coli. |
| Q90418737 | Mammalian membrane trafficking as seen through the lens of bacterial toxins |
| Q36973773 | Mapping the minimal contiguous gene segment that encodes functionally active Shiga-like toxin II |
| Q35762828 | Maturational regulation of globotriaosylceramide, the Shiga-like toxin 1 receptor, in cultured human gut epithelial cells |
| Q47127903 | Microvesicle Involvement in Shiga Toxin-Associated Infection |
| Q40154302 | Modification of the glycolipid-binding specificity of vero cytotoxin by polymyxin B and other cyclic amphipathic peptides |
| Q33517206 | Molecular cloning of pigeon UDP-galactose:beta-D-galactoside alpha1,4-galactosyltransferase and UDP-galactose:beta-D-galactoside beta1,4-galactosyltransferase, two novel enzymes catalyzing the formation of Gal alpha1-4Gal beta1-4Gal beta1-4GlcNAc se |
| Q52040660 | Neutral glycolipids of human and bovine milk |
| Q28477426 | Oligosaccharide binding proteins from Bifidobacterium longum subsp. infantis reveal a preference for host glycans |
| Q37119923 | Ouabain protects against Shiga toxin-triggered apoptosis by reversing the imbalance between Bax and Bcl-xL. |
| Q34992431 | P1 Trisaccharide (Galalpha1,4Galbeta1,4GlcNAc) synthesis by enzyme glycosylation reactions using recombinant Escherichia coli |
| Q34578986 | Pathogenesis of Shigella diarrhea. XVI. Selective targetting of Shiga toxin to villus cells of rabbit jejunum explains the effect of the toxin on intestinal electrolyte transport |
| Q33999166 | Prevalence of known P-fimbrial G alleles in Escherichia coli and identification of a new adhesin class. |
| Q90130381 | Progress in the understanding and treatment of Fabry disease |
| Q39122055 | Protection against Shiga Toxins |
| Q40856041 | Protein toxins acting on intracellular targets: cellular uptake and translocation to the cytosol |
| Q35772225 | Proteolytic activation of bacterial toxins: role of bacterial and host cell proteases |
| Q37174239 | Rapid method to detect shiga toxin and shiga-like toxin I based on binding to globotriosyl ceramide (Gb3), their natural receptor |
| Q37843686 | Receptor mimicry as novel therapeutic treatment for biothreat agents |
| Q35673972 | Reduced Toxicity of Shiga Toxin (Stx) Type 2c in Mice Compared to Stx2d Is Associated with Instability of Stx2c Holotoxin. |
| Q34582000 | Restricted expression of shiga toxin binding sites on mucosal epithelium of mouse distal colon |
| Q37171510 | Retrograde trafficking of AB₅ toxins: mechanisms to therapeutics |
| Q41903590 | Retrograde transport from the Golgi complex to the ER of both Shiga toxin and the nontoxic Shiga B-fragment is regulated by butyric acid and cAMP. |
| Q21245139 | Retrograde transport pathways utilised by viruses and protein toxins |
| Q38144759 | Ribosome-inactivating proteins: potent poisons and molecular tools |
| Q37953290 | Ricin and Shiga toxins: effects on host cell signal transduction |
| Q37014766 | Rise of the microbes |
| Q36211187 | Role of lipid rafts and flagellin in invasion of colonic epithelial cells by Shiga-toxigenic Escherichia coli O113:H21. |
| Q64992859 | Roles of Shiga Toxins in Immunopathology. |
| Q37610316 | Saccharide orientation at the cell surface affects glycolipid receptor function |
| Q40429422 | Secretory immunoglobulin A response to Shiga toxin in rabbits: kinetics of the initial mucosal immune response and inhibition of toxicity in vitro and in vivo |
| Q40200136 | Sensitive receptor-specified enzyme-linked immunosorbent assay for Escherichia coli verocytotoxin |
| Q36973479 | Serological responses to the B subunit of Shiga-like toxin 1 and its peptide fragments indicate that the B subunit is a vaccine candidate to counter action of the toxin |
| Q27021676 | Shiga Toxin (Stx) Classification, Structure, and Function |
| Q64055279 | Shiga Toxin Type 1a (Stx1a) Reduces the Toxicity of the More Potent Stx2a and |
| Q96306118 | Shiga Toxin-Bearing Microvesicles Exert a Cytotoxic Effect on Recipient Cells Only When the Cells Express the Toxin Receptor |
| Q44652100 | Shiga Toxins Induce Apoptosis and ER Stress in Human Retinal Pigment Epithelial Cells |
| Q33963113 | Shiga toxin 2 and flagellin from shiga-toxigenic Escherichia coli superinduce interleukin-8 through synergistic effects on host stress-activated protein kinase activation |
| Q33402959 | Shiga toxin in enterohemorrhagic E.coli: regulation and novel anti-virulence strategies |
| Q26850758 | Shiga toxin interaction with human intestinal epithelium |
| Q33397541 | Shiga toxin pathogenesis: kidney complications and renal failure |
| Q37357868 | Shiga toxin type 2dact displays increased binding to globotriaosylceramide in vitro and increased lethality in mice after activation by elastase |
| Q33384145 | Shiga toxin-associated hemolytic-uremic syndrome: combined cytotoxic effects of Shiga toxin, interleukin-1 beta, and tumor necrosis factor alpha on human vascular endothelial cells in vitro |
| Q30439707 | Shiga toxin-mediated disease in MyD88-deficient mice infected with Escherichia coli O157:H7. |
| Q37659792 | Shiga toxins--from cell biology to biomedical applications |
| Q28378807 | Sorting of newly synthesized galactosphingolipids to the two surface domains of epithelial cells |
| Q28743696 | Specific egg yolk immunoglobulin as a new preventive approach for Shiga-toxin-mediated diseases |
| Q37207385 | Structural analysis of N-glycans from gull egg white glycoproteins and egg yolk IgG. |
| Q90403584 | Super-Resolution Microscopy Reveals Local Accumulation of Plasma Membrane Gangliosides at Neisseria meningitidis Invasion Sites |
| Q33398109 | The expression of blood group P1 in post-enteropathic haemolytic uraemic syndrome |
| Q33229926 | The glycosphingolipid globotriaosylceramide in the metastatic transformation of colon cancer |
| Q35773392 | The specific activities of Shiga-like toxin type II (SLT-II) and SLT-II-related toxins of enterohemorrhagic Escherichia coli differ when measured by Vero cell cytotoxicity but not by mouse lethality |
| Q55470613 | Toxins of Locus of Enterocyte Effacement-Negative Shiga Toxin-Producing Escherichia coli. |
| Q37608531 | Transcription of the Shiga-like toxin type II and Shiga-like toxin type II variant operons of Escherichia coli |
| Q33326649 | Tumor-specific Hsp70 plasma membrane localization is enabled by the glycosphingolipid Gb3. |
| Q37954271 | Verotoxin-1 treatment or manipulation of its receptor globotriaosylceramide (gb3) for reversal of multidrug resistance to cancer chemotherapy |
| Q28468751 | Virulence factors in Escherichia coli urinary tract infection |
Search more.